The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...

NEW YORK, May 19, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA during ...

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it has raised $20.3 million in new funding to scale up its U.S. presence ...

The Garden State is looking to grow into the next big biotech hub. The New Jersey Innovation Hub has tapped venture capital firm Portal Innovations to build a 30,000-square-foot incubator lab ...

Reuters spoke to seven biotech executives, investors, and consultants who said that the staff departures and policy changes at the FDA had prompted some firms to consider launching trials in other ...

Revvity also raised its sales outlook for the full year. Biotech firm Revvity (RVTY) posted first-quarter results that topped analysts' estimates. The company on Monday reported adjusted earnings ...

George Yancopoulos, co-founder of biotech company Regeneron, has purchased almost all of the condominium units in a mixed-use Tribeca building, according to city records made public this week.

The firm claimed the biotech market has seen a “significant shift” in recent years, leading to scarce investor financing for early-stage biotech firms. Battelle, a nonprofit Columbus-based ...

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.

He graduated from University of Wisconsin-Madison in 1998 with a bachelor’s degree in biochemistry, worked at the biotech firm Promega, and in 2005 received a PhD in pharmaceutical sciences from ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...